Thursday, February 09, 2006

Bayer Slips On FDA Trasylol Warning | newratings.com

Bayer Slips On FDA Trasylol Warning | newratings.com: "Bayer (BAY.ETR) -1.4% at EUR33.39, hemorrhaging slightly on back of FDA's warning on its Trasylol blood drug, say traders. Within a few minutes, around 700,000 shares were traded, says one. 'But that's an old story,' another trader says pointing to a previous study of the drug from January. (MOD/HAD)"